| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) | 
|---|
| 07/05/2000 | CN1258739A Recombined adenovirus expressing human interleukin 18 and its preparation and use | 
| 07/05/2000 | CN1258738A Recombined adenovirus expressing the stimulating factor of human granulocyte-macrophage colony and its preparation and use | 
| 07/05/2000 | CN1258737A Recombined toxin adenovirus mutant for treating cancer gene HER-2/neu overexpressed tumor | 
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes | 
| 07/04/2000 | US6083750 Adenovirus vectors | 
| 07/04/2000 | US6083684 Viral products | 
| 06/29/2000 | WO2000037942A1 Conjugates for detecting viruses that cause diseases of the respiratory tract and use thereof | 
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS | 
| 06/29/2000 | WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein | 
| 06/29/2000 | WO2000001409A3 Porcine circovirus and parvovirus vaccine | 
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors | 
| 06/28/2000 | EP1013771A1 Non-nuclear chromosomal transformation | 
| 06/28/2000 | EP1013757A2 Attenuated forms of bovine viral diarrhea virus | 
| 06/28/2000 | EP1012338A1 A tumor suppressor designated ts10q23.3 | 
| 06/28/2000 | EP1012321A2 Viral infection of cells using viral vectors | 
| 06/28/2000 | EP1012295A1 Alphavirus rna replicon systems | 
| 06/28/2000 | EP1012245A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein | 
| 06/28/2000 | EP1012244A1 Rhabdoviruses with reengineered coats | 
| 06/28/2000 | CN1258317A Process for expression of genes of dengue viruses | 
| 06/27/2000 | US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia | 
| 06/27/2000 | US6080571 Highly efficient production and isolation of viral particles utilizing tentacle anion exchange | 
| 06/27/2000 | US6080570 Method of producing a vaccine for Swine Infertility and Respiratory Syndrome | 
| 06/27/2000 | US6080569 Adenovirus vectors generated from helper viruses and helper-dependent vectors | 
| 06/27/2000 | US6080408 Particles contain mutations to reduce gag-dependent rna-packaging of the gag gene product, eliminate reverse transcriptase, integrase activity and rnase h activity of the pol gene product through genetic manipulation; vaccines; aids | 
| 06/27/2000 | CA2076744C Viral agent associated with mystery swine disease | 
| 06/22/2000 | WO2000036099A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase | 
| 06/22/2000 | WO2000036093A2 Intein-mediated cyclization of peptides | 
| 06/22/2000 | WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation | 
| 06/22/2000 | WO2000035479A1 Synthetic virus-like particles with heterologous epitopes | 
| 06/22/2000 | WO2000035478A1 Treatment of papillomavirus infections | 
| 06/22/2000 | WO2000023955A8 Virus-like particles for the induction of autoantibodies | 
| 06/22/2000 | CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof | 
| 06/22/2000 | CA2355934A1 Intein mediated cyclization of peptides | 
| 06/22/2000 | CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation | 
| 06/22/2000 | CA2354444A1 Synthetic virus-like particles with heterologous epitopes | 
| 06/22/2000 | CA2353866A1 Treatment of papillomavirus infections | 
| 06/22/2000 | CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof | 
| 06/21/2000 | EP1010981A1 Conjugates to detect viruses and their use | 
| 06/21/2000 | EP1010759A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus | 
| 06/21/2000 | EP1009809A2 Method for purifying and concentrating aav-2 and antigen portions thereof | 
| 06/21/2000 | EP1009808A2 Methods for generating high titer helper-free preparations of recombinant aav vectors | 
| 06/20/2000 | US6077940 Free solution ligand interaction molecular separation method | 
| 06/20/2000 | US6077700 Amino acid sequence; for study of cell cycle | 
| 06/20/2000 | US6077691 Infecting mammalian kidney cell with chimeric vaccina virus with synthetic promoter linked to sequence that encodes pres1-pres2-s hepatitis antigen, culturing and lysing the infected cell, harvesting antigen | 
| 06/20/2000 | US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells | 
| 06/20/2000 | US6077659 Treating erythrocyte/photosensitizer composition with vitamin e, alpha-tocopherol phosphate, alpha-tocopherol succinate, or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 
| 06/20/2000 | US6077514 Characterized in that the viruses have a codon encoding an amino acid in the f protein chosen from specified amino acids at their amino acid numbers; temperature sensitive rsv phenotype; immunizing | 
| 06/20/2000 | US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | 
| 06/15/2000 | WO2000034529A1 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey | 
| 06/15/2000 | WO2000034495A2 A method of genetically modifying very primitive quiescent human hematopoietic stem cells | 
| 06/15/2000 | WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof | 
| 06/15/2000 | WO2000034446A1 Inactivation of non-enveloped viruses | 
| 06/15/2000 | WO2000034445A2 Live attenuated venezuelan equine encephalitis vaccine | 
| 06/15/2000 | WO2000034444A2 Method and composition for preserving viruses | 
| 06/15/2000 | WO2000011151A3 Direct oviduct transgenesis | 
| 06/15/2000 | WO1999061052A9 Oral immunization with papillomavirus virus-like particles | 
| 06/15/2000 | DE19823250C1 Continuous preparation of pathological viruses or recombinant proteins comprising infecting cells kept within a hollow sphere within a vessel while providing the cells with nutrients | 
| 06/15/2000 | CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof | 
| 06/15/2000 | CA2354374A1 Live attenuated venezuelan equine encephalitis vaccine | 
| 06/15/2000 | CA2351890A1 Method and composition for preserving viruses | 
| 06/14/2000 | EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines | 
| 06/14/2000 | EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta | 
| 06/14/2000 | EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same | 
| 06/14/2000 | EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze | 
| 06/14/2000 | EP1007641A1 Adenoviruses having altered hexon proteins | 
| 06/14/2000 | EP1007640A1 New spumavirus isolated from humans | 
| 06/14/2000 | EP1007637A1 Methods for increasing the efficiency of recombinant aav product | 
| 06/14/2000 | EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders | 
| 06/14/2000 | CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses | 
| 06/14/2000 | CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line | 
| 06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents | 
| 06/09/2000 | CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines | 
| 06/08/2000 | WO2000032755A1 Stable, attenuated rabies virus mutants and live vaccines thereof | 
| 06/08/2000 | WO2000032754A1 An improved method for the production and purification of adenoviral vectors | 
| 06/08/2000 | WO2000032753A1 Heat inactivated retrovirus preparations | 
| 06/08/2000 | WO2000032625A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands | 
| 06/08/2000 | WO2000032227A2 Ordered molecular presentation of antigens, method of preparation and use | 
| 06/08/2000 | WO2000032226A2 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof | 
| 06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization | 
| 06/08/2000 | WO2000015820A8 Adenovirus vectors containing cell status-specific response elements and methods of use thereof | 
| 06/08/2000 | WO2000008191A3 Herpes virus vectors for dendritic cells | 
| 06/08/2000 | CA2851896A1 Plant diacylglycerol acyltransferases | 
| 06/08/2000 | CA2354183A1 Ordered molecular presentation of antigens, method of preparation and use | 
| 06/08/2000 | CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands | 
| 06/08/2000 | CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization | 
| 06/07/2000 | EP1006178A2 An immortal cell line derived from grouper Epinephelus coioides and its applications | 
| 06/07/2000 | EP1005561A1 Vector and viral vectors, and packaging cell lines for propagating same | 
| 06/07/2000 | EP1005535A1 Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof | 
| 06/07/2000 | EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors | 
| 06/07/2000 | EP1005376A1 Methods and compositions for use in gene therapy for treatment of hemophilia | 
| 06/07/2000 | EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof | 
| 06/07/2000 | EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection | 
| 06/07/2000 | CN1255543A Process for increasing output of hallworm virus | 
| 06/06/2000 | US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines | 
| 06/06/2000 | US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus | 
| 06/06/2000 | US6071730 Cell ablation using trans-splicing ribozymes | 
| 06/06/2000 | US6071692 Inserting exogenous genes into cells; inserting gene into plasmid and transforming cell | 
| 06/06/2000 | US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence | 
| 06/02/2000 | WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors | 
| 06/02/2000 | WO2000031236A2 Vectors for gene mutagenesis and gene discovery by gene trapping |